LEDGIN6 - Moligand™,10mM in DMSO , CAS No.957890-42-5

CAS: 957890-42-5 Cat. No.: L655149 Formule: C21H20ClNO2 Poids moléculaire: 353.84 PubChem CID: 24800940
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Taille
USA
Allemagne (EU)*
Prix
Qté
1ml
L655149-1ml
Sur commande · 8–12 semaines
377,90$US
Enter a quantity for the sizes you want to add.

Vue d’ensemble

LEDGIN6 (CX05168) is a quinoline-based protein-protein interaction inhibitor of LEDGF/p75 and HIV integrase.

Spécifications

Spécifications et pureté
Moligand™,10mM in DMSO
Mécanismes biochimiques et physiologiques
LEDGIN6 (CX05168) is a quinoline-based protein-protein interaction inhibitor of LEDGF/p75 and HIV integrase.
Conditions de stockage de stockage
Store at -80°C
Expédié en
Dry ice packs + Cold packs
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Grade
Moligand™
Type d'action
INHIBITOR
Noms et identifiants
Isomères SMILES
CCCC(C1=C(N=C2C=CC(=CC2=C1C3=CC=CC=C3)Cl)C)C(=O)O
PubChem CID
24800940
Poids moléculaire
353.84

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

The manufacturer provides no validated assay protocols for LEDGIN6 in this listing. The following are general, non-item-specific guidelines for small‑molecule evaluation; adapt to your target and assay format.

Typical small-molecule screening workflow (general)

  • Stock preparation: Dissolve in anhydrous DMSO to 10 mM. Confirm solubility visually and, if possible, by LC.
  • Plate handling: Prepare serial dilutions in DMSO (e.g., 3-fold) and back-dilute into assay buffer to desired final concentrations, maintaining a constant final DMSO percentage across all wells.
  • Controls: Include vehicle controls, positive controls (known actives), and orthogonal counterscreens to detect assay interference (fluorescence quenchers, redox-cyclers, aggregators).
  • Readouts: For biochemical assays, employ initial-rate conditions and confirm reversibility if applicable. For biophysical assays (DSF, MST, SPR), optimize protein and compound concentrations to avoid nonspecific effects.
  • Data quality: Use duplicate/triplicate wells, Z′-factor monitoring, and concentration–response fitting (4-parameter logistic) with appropriate upper/lower bounds.

Documentation

  • Record lot number/SKU, stock concentration, preparation date, and freeze–thaw history. Attach CoA and any provided structure file to your ELN entry.
Biological Roles

Item-specific biological function/target information is not provided in this listing. The following context pertains to the broader “LEDGIN” class and is offered as literature background only; it must not be ascribed to LEDGIN6 without verification from the CoA/primary sources.

  • Literature context: The term “LEDGIN” has appeared in studies describing small molecules developed to modulate a defined protein–protein interaction interface implicated in virology research (notably the LEDGF/p75–integrase interaction). Such compounds are used as chemical probes to interrogate molecular mechanisms, complex assembly, and downstream phenotypes in cell-based and biochemical assays.
  • Role in research: Chemical probes of protein–protein interactions are valuable for dissecting binding site hot-spots, cooperativity, and allosteric regulation. They can complement genetic perturbations by offering rapid, titratable, and reversible modulation.
  • Off-target considerations: PPI modulators can exhibit polypharmacology. Profiling across panels (enzymes, receptors, transporters) helps delineate on-target versus off-target effects.
  • ADME/PK (general): For cellular work, confirm permeability, efflux liability, and solubility. For biochemical assays, evaluate aggregation or fluorescence interference (use detergent controls, AMP/Tris vs HEPES comparisons).

Important

  • No specific biological activity, potency, or selectivity is claimed for LEDGIN6 in this catalog entry. Users should determine suitability and mechanism empirically and consult the SDS/CoA for any target annotations that may be provided with their lot.
Buffer Applications

Not typically applicable. LEDGIN6 is a discrete small molecule rather than a buffering agent. It does not constitute a defined buffer system.

Practical notes for assay buffers (general guidance)

  • Prepare compound stocks in DMSO and dilute into assay buffers (e.g., PBS, HEPES, Tris) ensuring final DMSO ≤0.5–1.0% where possible and consistent across controls.
  • Include low levels of nonionic detergent (e.g., 0.01–0.05% Tween‑20) to mitigate colloidal aggregation artifacts when screening hydrophobic small molecules.
  • Verify compound stability in the chosen buffer over the assay time course (e.g., 4–24 h) via LC or UV to rule out precipitation or degradation.

For precise buffer recipes or pH ranges, refer to the requirements of your biological assay; none are intrinsic to this item.

Green Alternatives

As a discrete small molecule used at micro- to milligram scales in discovery assays, the major environmental leverage points are in solvent and consumable choices rather than the compound itself.

Greener solvent strategies (general guidance)

  • Primary stock solvent: Consider using high-purity DMSO with responsible handling; while not “green,” it allows low-volume stocks that minimize waste. Where solubility permits, ethanol or water with minimal cosolvent can reduce environmental impact, but verify assay compatibility.
  • Assay buffers: Optimize to tolerate ≤0.5–1.0% DMSO. This reduces solvent load in downstream aqueous waste.
  • Chromatography: Prefer ACN over chlorinated solvents; evaluate methanol/water gradients when feasible. Supercritical CO2 (SFC) can reduce organic solvent consumption for purification (if applicable).

Comparison of common solvent options (literature, general)

  • DMSO: Excellent solubility; moderate toxicity; challenging biodegradability considerations; easily recovered in some processes.
  • Ethanol: Renewable feedstock, lower toxicity; limited solubility window; may perturb protein assays.
  • 2-MeTHF/CPME (for synthesis/purification contexts): Bio-derived options compared to THF/Et2O; not typically used in assay stocks but useful for greener extractions.

Operational practices

  • Prepare concentrated stocks to minimize volume, aliquot to reduce repeated freeze–thaw, and scale assays to conserve reagents.
  • Consolidate solvent waste streams for appropriate recycling or disposal per institutional EHS guidance.
Pharmaceutical Uses

No pharmacopeial status or excipient role is provided for this item. LEDGIN6 is sold strictly for research use only and is not intended for human or veterinary use, diagnostics, or as an active pharmaceutical ingredient.

General formulation context for small-molecule probes (not item-specific)

  • Preclinical discovery studies may formulate small molecules for in vitro or ex vivo research. Typical vehicles include DMSO stocks diluted into aqueous buffers or, for nonclinical in vivo research, cosolvent systems (e.g., PEG400/saline) as allowed by institutional approvals. Such uses are outside the scope of this product listing and must follow institutional and regulatory guidance.
  • No claims are made regarding GMP status, residual solvents, elemental impurities, or compliance with pharmacopoeial monographs.

Important

  • Do not use in humans or for clinical purposes. For manufacturing or regulated applications, obtain appropriate GMP-grade materials and full regulatory documentation.
Physical Properties

Item-specific physicochemical data are not provided in this listing. Do not assume values; verify with the CoA/SDS for your lot.

Item-specific (specification)

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (mp): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (bp): Not applicable/rarely used for nonvolatile screening solids; Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable for solids; Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility in water/organic solvents: Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for small‑molecule screening probes (not item-specific)

  • Many drug-like heteroaromatics are sparingly soluble in water but dissolve readily in polar aprotic solvents (e.g., DMSO) at 10–50 mM for stock preparation. Always confirm solubility for this specific compound experimentally at your target concentration.
  • LogP, pKa, and PSA strongly impact solubility and assay behavior; when the structure is available, compute these to guide buffer composition (cosolvent %, surfactants) and plate handling.
  • Hygroscopicity and polymorphism can influence massing accuracy and solution stability; if unspecified, dry powders under vacuum and verify concentration by UV/LC where possible.

Important

  • Treat any unverified property as unknown. Establish solubility limits and stability empirically before scaling assays.
Quality and Grades
  • Grade: Moligand™

What Moligand™ implies (general description)

  • Moligand™ indicates a research-grade small-molecule intended for discovery chemistry, screening, and chemical biology. Emphasis is placed on identity confirmation and suitability for ligand/probe workflows rather than on chromatographic baselines required for reference standards.

Quality controls typically associated with this grade (general; not item-specific)

  • Identity confirmation by orthogonal methods (e.g., 1H NMR/LC–MS, HRMS). Purity assessment by LC–UV/LC–MS at multiple wavelengths. Water and residual solvent profiles may be included in the CoA.
  • Format readiness for screening (e.g., DMSO solubility check, micro-aliquoting) may be provided depending on lot.

Item-specific notes

  • Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet.
  • Formulation: Not specified for this item; refer to CoA/Spec Sheet.

Guidance for users

  • For HTS or biophysical assays, request the full CoA and, if needed, a QC data pack (chromatogram, mass spectrum). If low UV background or metal content is critical for your application, verify via the CoA prior to use.
  • If reference-standard performance is required (quantitative assays), consider in-house secondary qualification (qNMR, purity by area% with orthogonal detection) using your assay-relevant conditions.
Reaction and Applications

This product is supplied as a research small-molecule (Moligand™) and is not primarily intended as a synthetic reagent. No manufacturer application notes beyond “For research use only” are provided for this SKU.

General/literature context for LEDGIN-class probes (not item-specific)

  • The LEDGIN family name has been used in the literature for small molecules designed to modulate a defined protein–protein interaction interface relevant to virology research. Such compounds function as chemical probes in biochemical assays, biophysics (e.g., thermal shift, SPR), and cell-based mechanism studies. Use for target validation and mode-of-action exploration rather than as stoichiometric reagents.

Practical use cases in discovery workflows (general)

  • Assay deployment: evaluate binding or functional modulation in target-specific assays; implement serial dilutions from DMSO stocks with appropriate controls (vehicle, positive/negative comparators).
  • Orthogonal confirmation: combine biochemical readouts with biophysical measurements (DSF, MST) to confirm direct interaction where applicable.
  • Selectivity profiling: test across off-target panels if the structure/mechanism warrants.

Notes

  • Do not infer mechanism or target for LEDGIN6 without the structure/CoA and primary literature. All applications should be validated empirically under your laboratory conditions.
Reaction Conditions

Not applicable. LEDGIN6 is not supplied as a reagent for carrying out named organic reactions, and no manufacturer reaction conditions are provided.

General notes for handling in assay preparation (not item-specific)

  • Dissolution: Prepare concentrated stocks (e.g., 10 mM) in anhydrous DMSO; vortex and, if needed, brief sonication. Verify complete dissolution before dilution into assay media.
  • Stability checks: Evaluate stability of DMSO stocks at room temperature over bench time (e.g., up to several hours) and at storage temperature (−20 to −80°C) over weeks by LC–MS.
  • Light/air sensitivity: If the structure (when provided) suggests sensitivity (e.g., anilines, nitroso, photoactive motifs), handle under low light and inert atmosphere. In absence of item-specific data, adopt conservative protection (amber vials, desiccation).

Assay deployment

  • Perform serial dilutions in DMSO to minimize precipitation. Mix thoroughly when adding to aqueous buffers; consider intermediate dilutions to reduce localized supersaturation.
  • Include vehicle controls matching final DMSO percentage and, where relevant, detergent controls to detect aggregation artifacts.
Safety and Handling

Safety information specific to this item is not provided in the listing. Always consult the SDS for authoritative guidance.

GHS hazard information (item-specific)

  • Signal word: Not specified for this item; refer to SDS.
  • Hazard statements (H-phrases): Not specified for this item; refer to SDS.
  • GHS classification and pictograms: Not specified for this item; refer to SDS.

General laboratory precautions for small molecules (not item-specific)

  • PPE: Wear lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Handle powders and solutions in a certified fume hood to avoid inhalation and aerosol exposure.
  • Avoid ingestion, inhalation, and skin/eye contact. Prevent environmental release. Minimize dust generation during weighing.
  • Storage incompatibilities: Keep separate from strong oxidizers and strong acids/bases unless known to be compatible. Use inert, dry containers for long-term storage.
  • First aid overview: If inhaled—move to fresh air; if on skin—wash with soap/water; if in eyes—rinse cautiously with water for several minutes; if swallowed—rinse mouth. Seek medical attention in all exposure cases and provide the SDS.
  • Spill/accident: For small quantities, absorb with inert material and collect for disposal. Decontaminate area with suitable solvent while observing compatibility.

Special risks

  • Unknown sensitization or toxicity profile: adopt a conservative approach (treat as harmful). Use micro-aliquots to limit repeated thaw/freeze and handling time.
  • Waste: Dispose in accordance with institutional and local regulations for organic laboratory chemicals.
Solvent Selection

Item-specific solubility data are not provided. The following guidance reflects common practice for small-molecule screening compounds and should be verified experimentally for LEDGIN6.

  • Primary stock solvent (typical, literature practice): Anhydrous DMSO due to broad solvating power and assay compatibility. Start with 10 mM test concentration and adjust.
  • Cosolvents for aqueous assay buffers: 0.1–2% v/v DMSO is commonly tolerated in biochemical assays. For cell-free biophysics, higher DMSO may be acceptable; confirm tolerance with your assay system.
  • Alternative organic solvents (general): DMF, NMP, or ethanol can dissolve many heteroaromatics. Use caution with protein assays (ethanol) and with high-boiling solvents (DMF/NMP) due to carryover.
  • Polarity/dielectric context (general): DMSO (ε ~47, literature) and DMF (ε ~37) support dissolution of polar/heteroatom-rich scaffolds; ACN (ε ~37) can be useful for HPLC sample prep.

Practical tips

  • Warm gently (room temperature) and vortex/sonicate to assist dissolution; avoid heating above assay-relevant temperatures unless stability is confirmed.
  • Filter or centrifuge before plate loading to remove particulates. Quantify concentration by UV or LC when critical.
  • Avoid aqueous-only dissolution unless verified; many screening compounds are only sparingly water soluble without cosolvent or surfactant.

Comparison (general)

  • DMSO vs DMF: DMSO offers better biocompatibility but can oxidize sensitive motifs; DMF has lower viscosity but is less favored in biological assays. Choose based on assay tolerance and compound solubility.
Storage and Reconstitution

Item-specific storage and logistics

  • Storage Conditions: Store at −80°C (per product listing). Maintain in a tightly sealed, dry, inert container. Protect from moisture and prolonged light exposure as a conservative precaution.
  • Shipped In: Dry ice packs + cold packs, preserving ultra-low temperature during transit.

Reconstitution (general guidance; not item-specific)

  • Solvent: Use anhydrous DMSO for initial stock preparation unless the CoA specifies otherwise.
  • Concentration: Common starting stock is 10 mM; adjust based on solubility and assay needs. Verify complete dissolution (visual inspection, LC).
  • Aliquoting: Dispense into single-use micro-aliquots (e.g., 10–50 µL) to avoid repeated freeze–thaw cycles that can degrade sensitive compounds.
  • Storage of solutions: Store DMSO stocks at −80°C. If −80°C is unavailable for working stocks, −20°C may be used short term with stability verification. Minimize headspace and use inert gas overlay if oxidation is a concern.

Handling tips

  • Equilibrate frozen vials on ice, then to room temperature before opening to avoid condensation. Reseal promptly under dry atmosphere.
  • Track freeze–thaw count; discard aliquots after 1–2 thaws unless stability has been established.

Specifications not provided

  • Appearance, water content, stabilizers, and exact solubility: Not specified for this item; refer to CoA/Spec Sheet.

Research use note

  • For research use only.
Structure and Identity

Overview of the LEDGIN6 small‑molecule library member (research use only).

  • SKU: L655149
  • Product Name: LEDGIN6
  • CAS: 957890-42-5
  • PubChem CID: 24800940 (reference, literature)
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Synonyms: Not specified for this item; refer to CoA/Spec Sheet.

Structural description (general, literature context):

  • The “LEDGIN” designation in the literature refers to a family of small molecules developed as chemical probes to modulate a defined protein–protein interaction interface in virology research (e.g., the LEDGF/p75–integrase interface). The exact scaffold and substituent pattern for LEDGIN6 are not specified in this product entry; consult the CoA or structure file provided with your lot for definitive structural features.
  • Typical LEDGIN-class chemotypes (literature) incorporate heteroaromatic cores and H‑bonding motifs tailored for hot‑spot recognition at protein interfaces; however, this should not be assumed for this specific item without the provided structure.

Notes

  • For unambiguous identification in data systems, use the CAS and SKU above and attach the vendor CoA/structure file when available.
  • If you require canonical identifiers (InChI, SMILES) for informatics workflows, request the structure package for this SKU or reference the CoA.
Synthetic Utility

Not a general-purpose synthetic reagent. LEDGIN6 is supplied as a discrete, research-grade small molecule (Moligand™) for screening and chemical biology.

General considerations (not item-specific)

  • If structural information is available from the CoA, analog design/SAR exploration can proceed by modifying heteroaromatic cores, substituent electronics, and H‑bonding motifs. Derivatization for probe development (e.g., biotinylation, photoaffinity tags) may be feasible if functional handles exist; confirm positions that tolerate modification via SAR.
  • For target engagement studies, installation of reporter groups (fluorophores, linkers) often requires amide coupling, click chemistry, or SNAr on appropriately functionalized analogs. Ensure modifications preserve physicochemical properties compatible with the assay.

Caveats

  • Without the disclosed structure, specific reactivity, protecting-group strategies, or cross-coupling handles cannot be provided. Request the structure package to plan any semi-synthesis or tagging chemistry.
  • If the compound is needed as a starting point for library expansion, consider parallel synthesis guided by computed properties (cLogP, pKa) and maintain solubility across the designed set.
Target Specificity

No item-specific target, epitope, or biological selectivity data are provided for LEDGIN6 in this listing.

  • Target/Mechanism: Not specified for this item; refer to CoA/Spec Sheet and primary literature if supplied.
  • Species reactivity, clone, isotype: Not applicable (small molecule, not an antibody or biologic).

Note

  • The “LEDGIN” name has appeared in literature describing modulators of a defined protein–protein interaction interface relevant to virology research; however, do not ascribe that specificity to this SKU without verification from authoritative documentation accompanying your lot.

Besoin d'aide pour choisir la qualité ?

Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.

Voir le guide des qualités Moligand™ →

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.